Key facts
- This page summarizes Dusty Tenney's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 May 2021, 20:00.
Dusty Tenney - 03 May 2021 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Reporting relationship
- COO and President
- Issuer ticker
- BLFS
- Reported as of
- 03 May 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Dusty Tenney
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Dusty Tenney filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 13 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLFS
transaction
Common Stock
Award
- Transaction value
- Shares
- +32,079
- Change %
- Price
- Shares after
- 32,079
- Date
- 03 May 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BLFS
transaction
Derivative
Restricted Stock Award
Award
- Transaction value
- $0
- Shares
- +6,415
- Change %
- Price
- $0.000000
- Shares after
- 6,415
- Date
- 03 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,415
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock granted pursuant to the Biolife Solutions 2013 Performance Incentive Plan (the "Plan"), as amended, of Biolife Solutions, Inc. (the "Company") on July 17, 2020 and vests 25% on the first anniversary of the grant date and thereafter yearly, in 4 equal annual installments. The restricted stock was granted to the reporting person as part of the reporting person's compensation for service to the Company.
Footnote F2
The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.